WFDC2 and cancer: In BRCA mutated population, the ROC analysis has shown that a pre-surgery level of HE4 is a good prognostic marker to predict relapse of cancer (p = 0.019), and also the level of HE4 measured during the 3rd cycle of chemotherapy has given statistically significant results (Figure 2).